AR |
androgen receptor |
AR-V7 |
an AR splice variant |
ADT |
androgen deprivation therapy |
ARE |
androgen response element |
Bic |
bicalutamide |
CAF |
cancer-associated fibroblasts |
CRPC |
castration-resistant prostate cancer |
CTC |
circulating tumor cells |
CSC |
cancer stem cell |
DRPC |
drug resistance Pca |
DHT |
dihydrotestosterone |
EGFR |
epidermal growth factor receptor |
Enz |
enzalutamide |
EMT |
epithelial-mesenchymal transition |
GR |
glucocorticoid receptor |
LCoR |
ligand-dependent co-repressor |
mCRPC |
metastatic CRPC |
NLS |
nuclear localization signal |
NEPC |
neuroendocrine prostate cancer |
LBD |
ligand-binding domain |
NTD |
amino-terminal domain |
ODM |
darolutamide |
Pca |
prostate cancer |
PSA |
prostate specific antigen |
SFK |
Src family of kinases |